Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

• Váldodahkkit: Martínez del Prado P (Dahkki), Alvarez-López I (Dahkki), Domínguez-Fernández S (Dahkki), Plazaola A (Dahkki), Ibarrondo O (Dahkki), Galve-Calvo E (Dahkki), Ancizar-Lizarraga N (Dahkki), Gutierrez-Toribio M (Dahkki), Lahuerta-Martínez A (Dahkki), Mar J (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2018-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Purificación Martínez del Prado,1 Isabel Alvarez-López,2,3 Severina Domínguez-Fernández,4 Arrate Plazaola,5 Oliver Ibarrondo,6 Elena Galve-Calvo,1 Nerea Ancizar-Lizarraga,2,3 María Gutierrez-Toribio,4 Ainhara Lahuerta-Martínez,5 Javier Mar6,7 1Medical Oncology Service, Basurto University Hospital, B...